热门资讯> 正文
Movano Health获得纳斯达克批准上市延期
2025-08-29 04:44
- Movano(MOVE) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Movano Health (NASDAQ:MOVE) on Thursday said it received a listing extension from the Nasdaq Hearings Panel on August 27, 2025.
- Extension requires compliance with Listing Rule 5250(c)(1) by filing Q1 and Q2 2025 10-Qs by September 30, 2025.
- Must also comply with Listing Rule 5550(a)(2) requiring the maintenance of $1.00 per share bid price, on or before October 30, 2025.
- Panel decision follows August 19, 2025 hearing reviewing company's compliance plan.
- Additionally, on August 19, 2025, the company filed a Preliminary Proxy Statement for its Annual Shareholders Meeting to be held on September 26, 2025, at which the company's shareholders will have the opportunity to approve a reverse stock split proposal, the effect of which will allow the company to demonstrate compliance rule within the extension period granted by the panel.
- MOVE +17.61% after hours to $0.7264
- Source: Press Release
More on Movano
- Seeking Alpha’s Quant Rating on Movano
- Historical earnings data for Movano
- Financial information for Movano
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
